{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:18Z","timestamp":1793663898579,"version":"4.5.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2017.07.028","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T12:31:16Z","timestamp":1503491476000},"page":"2981-2987","source":"Crossref","is-referenced-by-count":14,"title":["Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease\u2014A Proteome Analysis of Cerebrospinal Fluid"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-1382","authenticated-orcid":false,"given":"Daina","family":"Kashiwazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruto","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0010","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0025","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0030","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3171\/jns.1998.89.4.0623","article-title":"Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease","volume":"89","author":"Hojo","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0035","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1161\/01.STR.0000100159.43123.D7","article-title":"Elevation of CRABP-I in the cerebrospinal fluid of patients with moyamoya disease","volume":"34","author":"Kim","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0040","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.STR.0000148237.13659.e6","article-title":"Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease","volume":"35","author":"Nanba","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0045","first-page":"544","article-title":"Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome","volume":"50","author":"Soriano","year":"2002","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0050","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0304-3940(93)90416-I","article-title":"The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor","volume":"160","author":"Takahashi","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2176\/nmc.52.245","article-title":"Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis)","volume":"52","author":"Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/elps.1150180305","article-title":"Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients","volume":"18","author":"Sanchez","year":"1997","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0065","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/elps.11501501223","article-title":"Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension","volume":"15","author":"Rabilloud","year":"1994","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0070","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/1522-2683(200011)21:17<3673::AID-ELPS3673>3.0.CO;2-M","article-title":"A comparison of silver stain and SYPRO Ruby Protein Gel Stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling","volume":"21","author":"Lopez","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0075","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/(SICI)1522-2683(20000101)21:2<430::AID-ELPS430>3.0.CO;2-0","article-title":"Mass spectrometric approaches for the characterization of proteins on a hybrid quadrupole time-of-flight (Q-TOF) mass spectrometer","volume":"21","author":"Kristensen","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0080","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6","article-title":"Mass spectrometric identification of proteins from silver-stained polyacrylamide gel: a method for the removal of silver ions to enhance sensitivity","volume":"20","author":"Gharahdaghi","year":"1999","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0085","first-page":"170","article-title":"A cerebrospinal fluid protein associated with moyamoya disease: report of three cases","volume":"45","author":"Hojo","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2377-10-112","article-title":"Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS","volume":"10","author":"Araki","year":"2010","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1074\/jbc.M605684200","article-title":"A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex","volume":"282","author":"Nielsen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0100","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U","article-title":"Cytokines and the hepatic acute phase response","volume":"181","author":"Moshage","year":"1997","journal-title":"J Pathol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0105","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1172\/JCI116319","article-title":"Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis","volume":"91","author":"Cid","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1471-2407-8-241","article-title":"Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients","volume":"8","author":"Tian","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/1352458508100047","article-title":"Protein expression profiles in pediatric multiple sclerosis: potential biomarkers","volume":"15","author":"Rithidech","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3340\/jkns.2010.48.1.8","article-title":"Comparative analysis of serum proteomes of moyamoya disease and normal controls","volume":"48","author":"Koh","year":"2010","journal-title":"J Korean Neurosurg Soc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0125","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2217\/clp.10.37","article-title":"Apolipoproteins in the brain: implications for neurological and psychiatric disorders","volume":"51","author":"Elliott","year":"2010","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0130","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/S0022-2275(20)33324-1","article-title":"Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins","volume":"39","author":"Montine","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO;2-T","article-title":"Cerebrospinal fluid lipoproteins in Alzheimer's disease","volume":"50","author":"Bassett","year":"2000","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0140","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1136\/jnnp.2006.097543","article-title":"Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage","volume":"77","author":"Martinez-Gonzalez","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.febslet.2012.12.003","article-title":"Apolipoprotein e protects astrocytes from hypoxia and glutamate-induced apoptosis","volume":"587","author":"Zhou","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/01.STR.30.5.1118","article-title":"Apolipoprotein e deficiency worsens outcome from global cerebral ischemia in the mouse","volume":"30","author":"Sheng","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0155","first-page":"5","article-title":"The role of apolipoprotein E in the pathological events following subarachnoid hemorrhage: a review","volume":"110","author":"Guo","year":"2011","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0160","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1073\/pnas.92.11.4725","article-title":"Apolipoprotein E and Alzheimer disease","volume":"92","author":"Strittmatter","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","article-title":"Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood-brain barrier function in mice","volume":"35","author":"Alata","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0170","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.brainresbull.2012.05.006","article-title":"Clusterin in neurological disorders: molecular perspectives and clinical relevance","volume":"88","author":"Charnay","year":"2012","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0175","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nm0901-977","article-title":"Inhibition of post-ischemic brain injury by clusterin overexpression","volume":"7","author":"Wehrli","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0180","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.nbd.2005.11.009","article-title":"Sustained astrocytic clusterin expression improves remodeling after brain ischemia","volume":"22","author":"Imhof","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0185","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/ATVBAHA.109.190058","article-title":"Protective role of clusterin\/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells","volume":"29","author":"Kim","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0190","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/CIRCULATIONAHA.112.108753","article-title":"Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling","volume":"127","author":"Riwanto","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jstrokecerebrovasdis.2017.07.028_bib0195","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1227\/01.NEU.0000232771.80339.15","article-title":"Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease","volume":"59","author":"Takagi","year":"2006","journal-title":"Neurosurgery"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305717303993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305717303993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T17:24:23Z","timestamp":1659374663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305717303993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1052305717303993"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.07.028","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}